Published in N Engl J Med on June 20, 1996
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut (1999) 0.93
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci (2005) 0.87
Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol (2016) 0.85
Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc (2012) 0.83
Endoscopic management of esophageal varices. World J Gastrointest Endosc (2012) 0.81
The risk factors for bleeding of fundal varices in patients with liver cirrhosis. Gut Liver (2013) 0.81
Hepatic venous pressure gradient: worth another look? Dig Dis Sci (2008) 0.80
When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Langenbecks Arch Surg (2003) 0.78
Current Management of Esophageal Varices. Curr Treat Options Gastroenterol (2003) 0.76
EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc (2016) 0.76
Hemodynamic effects of propranolol with spironolactone in patients with variceal bleeds: a randomized controlled trial. World J Gastroenterol (2008) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol (2013) 0.75
Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World J Gastroenterol (2017) 0.75
Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) (2017) 0.75
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med (2001) 2.52
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology (1995) 1.84
Endoscopic hemostasis by local injection of epinephrine and polidocanol in bleeding ulcer. A prospective randomized trial. Endoscopy (1988) 1.77
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology (1992) 1.71
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology (1993) 1.61
Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology (1999) 1.59
Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther (2007) 1.55
Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology (1996) 1.52
Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. Gastroenterology (1992) 1.49
Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol (2001) 1.46
[Gastric metastasis of breast carcinoma]. Rev Esp Enferm Dig (1997) 1.42
[Consensus on spontaneous bacterial peritonitis in liver cirrhosis: diagnosis, treatment, and prophylaxis]. Gastroenterol Hepatol (2001) 1.40
[Muscular pseudohypertrophy caused by chronic radiculopathy]. Neurologia (1992) 1.39
[Multiple cerebral cavernous angiomas and magnetic resonance]. Med Clin (Barc) (1993) 1.38
Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A (2006) 1.36
Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial. Gastrointest Endosc (1994) 1.18
Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci (2001) 1.13
Spontaneous bacterial peritonitis. Semin Liver Dis (1997) 1.11
Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol (1994) 1.09
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol (2000) 1.07
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology (2001) 1.04
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology (1997) 1.03
High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum Gene Ther (1996) 1.03
Gastric emptying of solid and liquid meals in healthy young subjects. Scand J Gastroenterol (1984) 1.01
Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med (1993) 0.99
Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med (2000) 0.99
Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment Pharmacol Ther (2008) 0.98
Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology (1995) 0.97
Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology (1991) 0.97
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology (1999) 0.96
Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection. Dig Dis Sci (1993) 0.95
An evaluation of gastric biopsy in the diagnosis of gastric cancer. Gastrointest Endosc (1978) 0.93
Gastric emptying in marathon runners. Gut (1989) 0.93
Injection therapy of bleeding peptic ulcer. A prospective, randomized trial using epinephrine and thrombin. Endoscopy (1990) 0.93
Endoscopic injection therapy of bleeding ulcer: a prospective and randomized comparison of adrenaline alone or with polidocanol. J Clin Gastroenterol (1993) 0.92
Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis. Aliment Pharmacol Ther (2010) 0.92
Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol (1988) 0.92
Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology (2001) 0.92
Wireless capsule video endoscopy: a new diagnostic method for aortoduodenal fissure. Endoscopy (2002) 0.91
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Aliment Pharmacol Ther (2008) 0.90
Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int J Tuberc Lung Dis (1998) 0.89
Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol (1995) 0.89
Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy (1995) 0.88
Foreign body granulomatous reaction to silica, silicone, and hyaluronic acid in a patient with interferon-induced sarcoidosis. Actas Dermosifiliogr (2012) 0.88
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. J Hepatol (2000) 0.88
Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology (1992) 0.87
Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology (1999) 0.87